ZYMOGENETICS INC ZGEN (NASDAQ)

$ 8.05
16:19
Change: -0.16 (-1.95%)
Volume: 573,518

Avg. Volume: 381701
P/E Ratio: 0
EPS (Annual): -2.27
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 68,700
Institutional Shareholders: 59.53%
Last: 8.05
Change: -0.16 (-1.95%)
Prev. Close: 8.21
Open: 8.16
Day's Range: 8.00 - 8.32
52wk Range: 7.51 - 15.23
Market Value: 569,520
Beta: 1.36
12-month EPS Change: 10.19%
Total Return Last 12 Months: -38.18%
Total Return Last 3 Years: -61.90%
Total Return Last 5 Years: -39.81%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on ZGEN
Alert me Subscribe

ZymoGenetics gets $100M investment from holder

(SEATTLE)Drug developer ZymoGenetics Inc. said Monday it has received $100 million in financing from shareholder Deerfield Management. Under terms of the agreement, Deerfield has committed ...READ MORE
Jun 30, 2008 7:36AM
Keywords: ZGEN

ZymoGenetics gets OK for blood-clotting drug size

(SEATTLE)ZymoGenetics Inc. said Tuesday the Food and Drug Administration approved a larger vial size for the biotechnology company's blood-clotting drug Recothrom Thrombin.READ MORE
May 27, 2008 10:19AM
Keywords: ZGEN

Earnings roundup: Churchill Downs, ZymoGenetics

Among the earnings stories for Tuesday, May 6, from AP Financial News: LOUISVILLE, Ky. (AP) _ Churchill Downs Inc., which operates the home of the Kentucky Derby and other racetrac...READ MORE
May 06, 2008 6:34PM
Keywords: CHDN, ZGEN, MFLX, THQI, PBI

Warburg Pincus Owns ZymoGenetics Stake

(NEW YORK)Warburg Pincus on Wednesday reported a 13.7 percent stake in biotechnology company ZymoGenetics Inc. in a filing with the Securities and Exchange Commission.READ MORE
Mar 12, 2008 9:09AM
Keywords: ZGEN

ZymoGenetics Gets FDA Nod for Recothrom

(SEATTLE)ZymoGenetics Inc. said Thursday it received Food and Drug Administration approval to market its surgical blood-clotting product Recothrom Thrombin. Shares of ZymoGenetics jumped $1...READ MORE
Jan 17, 2008 2:35PM
Keywords: ZGEN

ZymoGenetics Down on 'Sell' Initiation

(NEW YORK)Shares of biotechnology company ZymoGenetics Inc. fell Wednesday after a Brean Murray, Carret & Co. analyst started coverage with a "Sell" rating, saying the company's lead experim...READ MORE
Jan 16, 2008 1:39PM
Keywords: ZGEN, JNJ, KG

ZymoGenetics Falls on BofA Downgrade

(NEW YORK)Shares of ZymoGenetics Inc. fell sharply Tuesday after a Banc of America Securities analyst reduced his rating on the stock, citing potential difficulties in launching its lead blo...READ MORE
Dec 18, 2007 3:09PM
Keywords: ZGEN
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +41.30 63.81
GILEAD SCIENCES +39.10 54.15
BIOGEN IDEC INC -7.60 53.16
GENENTECH INC +43.70 97.43
AMYLIN PHARMA I -42.70 26.68